Efficacy of lipid lowering therapy in lower extremity artery disease and coronary artery disease undergoing revascularization

Key Points

• This study aims to assess the effectiveness of lipid lowering therapy in patients with lower extremity artery disease and coronary artery disease.
• Randomized trial design
• Included patients undergoing revascularization for coronary artery disease and lower extremity artery disease
• Outcomes measured post-intervention
• Lipid lowering therapy significantly improved cardiovascular outcomes (HR 0.75, 95% CI 0.60-0.93, p=0.02).
• Patients demonstrated a reduced incidence of revascularization events with therapy (OR 0.68, 95% CI 0.48-0.97, p=0.04).
• Overall mortality rates decreased in the treatment group compared to control.